CD4 and AIDS: People with human immunodeficiency virus (HIV) (PWH) on combination antiretroviral therapy (ART) usually achieve undetectable viral load and CD4+ ≥500 cells/mm3, decreasing the risk of developing acquired immune deficiency syndrome (AIDS)-related events, mortality, and transforming HIV infection into a chronic disease (Zicari et al., 2019).